Literature DB >> 18767132

Assessment of graft function in rodent models of heart transplantation.

Paulo Ney Aguiar Martins1.   

Abstract

Heterotopic heart transplantation in rats and mice is the most commonly used model to study allograft immune response and to test immunosuppressive drugs and tolerance induction protocols. Standardization of both the surgical procedure and the evaluation of graft function is essential for data interpretation. The most popular way to monitor graft function has been the palpation method. However, there are some proposal for more objective assessment methods like electrocardiogram and echocardiogram. Although, complementary tests might add some relevant information when assessing minor effects of immunosuppressive therapy, palpation by an experienced investigator is very predictive and so far the simplest method to determine heart allograft function. Minor complications during the surgical procedure and unreliable assessment can have a major impact on the interpretation of experiment results. Here, the author reviews the literature and presents some suggestions that help eliminating biases on the assessment of heart allograft function. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18767132     DOI: 10.1002/micr.20544

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  8 in total

1.  A simplified two-stitch sleeve technique for arterial anastomosis of cervical heterotopic cardiac transplantation in mice.

Authors:  Jing Fang; Long He; Shi-Qiang Wang; Ming-Jia Ma; Hong-Yun Liu; Xue-Hai Zhu; Ping Zhu; Xiang Wei; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2013-08-15       Impact factor: 4.060

2.  Cellular and Functional Imaging of Cardiac Transplant Rejection.

Authors:  Yijen L Wu; Qing Ye; Chien Ho
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

3.  Heterotopic Cervical Heart Transplantation in Mice.

Authors:  Thomas Ratschiller; Marcus-André Deutsch; Julia Calzada-Wack; Frauke Neff; Christiane Roesch; Ralf Guenzinger; Ruediger Lange; Markus Krane
Journal:  J Vis Exp       Date:  2015-08-25       Impact factor: 1.355

4.  Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent protein.

Authors:  Sonia Montanari; Xing-Hua Wang; Gustavo Yannarelli; Victor Dayan; Thorsten Berger; Larissa Zocche; Eiji Kobayashi; Sowmya Viswanathan; Armand Keating
Journal:  Transgenic Res       Date:  2014-07-11       Impact factor: 2.788

5.  Development of heterotopic transplantation of the testis with the epididymis to evaluate an aspect of testicular immunology in rats.

Authors:  Kai Yi; Naoyuki Hatayama; Shuichi Hirai; Ning Qu; Shogo Hayashi; Shinichi Kawata; Kenta Nagahori; Munekazu Naito; Masahiro Itoh
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

6.  Graft vasculopathy in a Wistar rat model of heterotopic heart transplantation depending on gender matching between donors and recipients.

Authors:  Joanna E Śliwka; Roman Przybylski; Anna Dołaszyńska-Żółkiewska; Adam Sokal; Mirosław Tyrpień; Piotr M Wilczek; Marian Zembala
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-09-24

7.  The heterotopic heart transplantation in mice as a small animal model to study mechanical unloading - Establishment of the procedure, perioperative management and postoperative scoring.

Authors:  Sumi Westhofen; Marisa Jelinek; Leonie Dreher; Daniel Biermann; Jack Martin; Helga Vitzhum; Hermann Reichenspurner; Heimo Ehmke; Alexander Peter Schwoerer
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

8.  CXCR4 blockade reduces the severity of murine heart allograft rejection by plasmacytoid dendritic cell-mediated immune regulation.

Authors:  Jian Fu; Christian H K Lehmann; Xinning Wang; Mandy Wahlbuhl; Ida Allabauer; Benjamin Wilde; Lukas Amon; Sebastian Dolff; Robert Cesnjevar; Andreas Kribben; Joachim Woelfle; Wolfgang Rascher; Peter F Hoyer; Diana Dudziak; Oliver Witzke; André Hoerning
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.